罗尼通过增强自和保持线粒体功能来减轻脏间歇性纤维化
Wenlin Liu1, Hongli Zhou1, Haonan Dong1
1Department of Nephrology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, 121001, China.
Cell biochemistry and biophysics
|September 22, 2023
概括
芬 (AKF-PD) 通过抑制NLRP3炎症酶通路,有效治疗纤维化. 这种新的皮里剂还可以改善线粒体功能并调节自,提供一种新的治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 芬 (AKF-PD) 是一种新型的胺剂,具有已知的抗NLRP3炎症和抗纤维性活性.
- 它的药理作用的确切机制仍然不完全理解.
研究的目的:
- 阐明黄 (AKF-PD) 在缓解纤维化方面的潜在机制.
- 在纤维化模型中研究AKF-PD对NLRP3炎症酶,线粒体功能和自的作用.
主要方法:
- 通过单边尿路阻塞 (UUO) 诱导了一种小鼠纤维化模型.
- 鼠被用AKF-PD或不使用AKF-PD治疗了3天和7天.
- 评估了纤维化,NLRP3炎症酶激活,线粒体功能和自性. 分析了用LPS和ATP刺激的巨细胞.
主要成果:
- 在UUO大鼠中,AKF-PD治疗显著降低了纤维化.
- AKF-PD降低了线粒体功能障碍,IL-1β和caspase-1的表达,并减少了线粒体ROS的产生.
- AKF-PD减弱了PI3K/AKT/mTOR信号传递,增强了自 (贝克林-1,LC3II,自细胞形成),并改善了线粒体损伤.
结论:
- 治疗AKF-PD可以抑制脏间歇性纤维化.
- 该机制涉及对自-线粒体-NLRP3炎症酶通路的调节.
相关概念视频
Renal Failure: Dose Adjustments
109
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
109
Heart Failure Drugs: Diuretics
412
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
412
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
454
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
454
Renal Drug Excretion: Tubular Secretion
210
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
210
Acute Kidney Injury V: Interprofessional Care
12
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
12
Renal Drug Excretion: Tubular Reabsorption
206
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
206


